DEF 14A

Company

Cardiff Oncology, Inc.

Filed

March 31, 2016

Period of Report

May 17, 2016

Accession Number

0001047469-16-011755

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →